Fondazione Telethon announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Waskyra, an ex vivo gene therapy for patients with Wiskott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback